AbbVie Inc.

NYSE: ABBV · Real-Time Price · USD
205.09
0.41 (0.20%)
At close: Aug 15, 2025, 9:57 AM

AbbVie Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
5.52B 12.81B 9.2B 9.75B
Short-Term Investments
31M 2M 28M 84M
Long-Term Investments
279M 304M 241M 277M
Other Long-Term Assets
9.14B 8.51B 5.57B 4.88B
Receivables
10.92B 11.15B 11.25B 9.98B
Inventory
4.18B 4.1B 3.58B 3.13B
Other Current Assets
4.93B 4.93B 4.4B n/a
Total Current Assets
25.58B 33B 28.46B 27.93B
Property-Plant & Equipment
5.13B 4.99B 4.93B 5.11B
Goodwill & Intangibles
95.02B 87.9B 99.59B 108.33B
Total Long-Term Assets
109.58B 101.71B 110.34B 118.6B
Total Assets
135.16B 134.71B 138.81B 146.53B
Account Payables
2.94B 3.69B 2.93B 2.88B
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
6.8B 7.19B 4.3B 12.67B
Other Current Liabilities
27.01B 25.16B 20.93B 17.85B
Total Current Liabilities
38.75B 37.84B 29.54B 35.19B
Long-Term Debt
60.34B 52.17B 59.12B 64.16B
Other Long-Term Liabilities
24.38B 24.91B 23.4B 22.02B
Total Long-Term Liabilities
93.05B 86.47B 91.98B 95.9B
Total Liabilities
131.8B 124.31B 121.52B 131.09B
Total Debt
67.84B 60.12B 64.19B 77.58B
Common Stock
18M 18M 18M 18M
Retained Earnings
-7.9B -1B 4.78B 3.13B
Comprehensive Income
-1.93B -2.31B -2.2B -2.9B
Shareholders Equity
3.33B 10.36B 17.25B 15.41B
Total Investments
310M 306M 269M 361M